enVVeno Medical (NVNO) Projected to Post Quarterly Earnings on Thursday

enVVeno Medical (NASDAQ:NVNO) is anticipated to announce its earnings results before the market opens on Thursday, March 6th. Analysts expect the company to announce earnings of ($0.35) per share for the quarter.

enVVeno Medical Trading Up 1.1 %

enVVeno Medical stock opened at $3.53 on Thursday. The firm’s 50 day simple moving average is $3.25 and its 200 day simple moving average is $3.71. enVVeno Medical has a 1-year low of $2.45 and a 1-year high of $6.97. The firm has a market capitalization of $61.90 million, a PE ratio of -2.74 and a beta of 1.22.

About enVVeno Medical

enVVeno Medical Corporation (Nasdaq: NVNO) is an medical device company focused on the development of innovative bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. The company’s lead product, the VenoValve®️, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI).